Free Trial

Ryan Specialty (NYSE:RYAN) Sets New 52-Week Low - Time to Sell?

Ryan Specialty logo with Finance background

Key Points

  • Shares of Ryan Specialty Holdings Inc. recently hit a new 52-week low, trading at $53.97, with analysts giving mixed recommendations and price target adjustments.
  • Despite the low stock price, the company reported a 23% year-over-year increase in revenue for the last quarter, achieving $855.17 million, and met the consensus EPS estimate of $0.66.
  • Ryan Specialty's recent quarterly dividend was $0.12 per share, leading to a 0.9% yield, although the company's dividend payout ratio stands at a high 137.14%.
  • MarketBeat previews top five stocks to own in October.

Shares of Ryan Specialty Holdings Inc. (NYSE:RYAN - Get Free Report) reached a new 52-week low on Monday . The stock traded as low as $53.97 and last traded at $54.10, with a volume of 2715 shares. The stock had previously closed at $54.39.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. UBS Group lowered their price target on Ryan Specialty from $84.00 to $80.00 and set a "buy" rating on the stock in a report on Monday, August 4th. Citigroup initiated coverage on Ryan Specialty in a report on Wednesday, August 13th. They issued a "buy" rating and a $74.00 price objective for the company. Wells Fargo & Company decreased their target price on Ryan Specialty from $63.00 to $60.00 and set an "equal weight" rating on the stock in a research report on Friday, August 1st. Cantor Fitzgerald upgraded Ryan Specialty to a "hold" rating in a report on Wednesday, August 13th. Finally, Wall Street Zen raised Ryan Specialty from a "sell" rating to a "hold" rating in a research report on Sunday, August 3rd. Nine research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $74.83.

Read Our Latest Research Report on Ryan Specialty

Ryan Specialty Stock Performance

The stock has a 50 day simple moving average of $61.41 and a two-hundred day simple moving average of $66.60. The company has a market capitalization of $14.36 billion, a price-to-earnings ratio of 155.31, a PEG ratio of 1.51 and a beta of 0.64. The company has a debt-to-equity ratio of 2.88, a current ratio of 1.01 and a quick ratio of 1.01.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The company reported $0.66 EPS for the quarter, hitting the consensus estimate of $0.66. Ryan Specialty had a return on equity of 48.70% and a net margin of 6.81%.The business had revenue of $855.17 million for the quarter, compared to analyst estimates of $837.52 million. During the same quarter in the previous year, the company earned $0.58 EPS. The company's quarterly revenue was up 23.0% on a year-over-year basis. As a group, analysts anticipate that Ryan Specialty Holdings Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, August 26th. Investors of record on Tuesday, August 12th were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Tuesday, August 12th. This represents a $0.48 annualized dividend and a yield of 0.9%. Ryan Specialty's dividend payout ratio (DPR) is currently 137.14%.

Insider Transactions at Ryan Specialty

In related news, EVP Mark Stephen Katz sold 14,377 shares of the stock in a transaction on Friday, June 13th. The stock was sold at an average price of $65.84, for a total transaction of $946,581.68. Following the completion of the sale, the executive vice president directly owned 1,117 shares in the company, valued at approximately $73,543.28. This trade represents a 92.79% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 52.21% of the company's stock.

Institutional Investors Weigh In On Ryan Specialty

A number of institutional investors have recently made changes to their positions in RYAN. Whittier Trust Co. of Nevada Inc. boosted its holdings in shares of Ryan Specialty by 281.6% during the 1st quarter. Whittier Trust Co. of Nevada Inc. now owns 332 shares of the company's stock valued at $25,000 after acquiring an additional 245 shares in the last quarter. SVB Wealth LLC acquired a new position in Ryan Specialty during the 1st quarter valued at about $26,000. WPG Advisers LLC purchased a new position in shares of Ryan Specialty in the 1st quarter worth approximately $32,000. Golden State Wealth Management LLC raised its holdings in shares of Ryan Specialty by 10,975.0% in the 2nd quarter. Golden State Wealth Management LLC now owns 443 shares of the company's stock worth $30,000 after purchasing an additional 439 shares during the period. Finally, Central Pacific Bank Trust Division bought a new stake in shares of Ryan Specialty in the 2nd quarter worth approximately $31,000. Institutional investors own 84.82% of the company's stock.

Ryan Specialty Company Profile

(Get Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.